Latest Insights - page 68 | BiopharmaTrend

Rubedo Garners $40M to Advance Clinical Trials in Age-Related Diseases

Rubedo Life Sciences, a biopharmaceutical company specializing in the development of therapies targeting senescent cells associated with age-related diseases, has completed a $40 million Series A financing round led by …

Continue ›››

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

How Industry Embraces Organ-on-Chips: A 2024 Status Report

Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and conducted several exploratory studies The last 4 years have witnessed …

Continue ›››

Healthcare Industry Faces Cybersecurity Mismatch, According to Kroll's Latest Report

Kroll, a global leader in risk and financial advisory solutions, has unveiled findings from its recent "State of Cyber Defense: Diagnosing Cyber Threats in Healthcare" report. This study highlights a …

Continue ›››

Isospec Analytics Secures $1.9 Million to Advance Biomolecular Identification Technology

Any given human blood sample has 15,000 small biological molecules that can give precise information about a person’s health at any given time. However, less than 5% of these molecules …

Continue ›››

Seed Health Unveils CODA: Pioneering Computational Biology Platform for Microbiome Research

Seed Health has announced the launch of CODA, a cutting-edge computational biology platform that utilizes the extensive data from the Human Phenotype Project. This project, led by Professor Eran Segal …

Continue ›››

A Closer Look at Elsevier's AI Strategy in Drug Discovery

My interview with Mirit Eldor, Managing Director, Life Sciences Solutions, at Elsevier, as we discuss Elsevier's recent collaboration with gen AI company Iktos and broader efforts.

Continue ›››

How AI Empowers Biomarker-Driven Clinical Trials

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert

In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of brain-computer interfaces (BCIs), a domain where the fusion of neuroscience …

Continue ›››

New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery

In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?," marking …

Continue ›››

It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?

The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning model proposed in the research paper Imagenet Classification with Deep …

Continue ›››